An Observational Study of Adherence to Adjuvant Anastrozole Therapy in Postmenopausal Patients With Early Breast Cancer Over One Year Follow-up.
Phase of Trial: Phase IV
Latest Information Update: 21 Jun 2011
At a glance
- Drugs Anastrozole (Primary)
- Indications Breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 21 Jun 2011 Last checked against ClinicalTrials.gov record.
- 21 Jun 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Dec 2010 Planned end date changed from 1 Aug 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov.